Daniel Halliday
Jun 2 · Last update 3 mo. ago.

Oklahoma vs Johnson & Johnson, could this case help beat the Opioid Epidemic?

The US has suffered for years with an Opioid Crisis, a problem of long term wide spread opiate addiction caused by the over prescription of opiate containing medication dating back to the 1990’s. Flooding the market with strong opiates caused abundance that has fuelled addiction, and has led to huge numbers of people moving on to other similar street drugs when they can no longer obtain or afford the prescription medication they have become dependent on. In a possibly precedent-setting case Oklahoma State have filed litigation against the pharmaceuticals giant Johnson & Johnson for their role in the state’s Opioid Epidemic. What effect could this case have on this massive social issue in the United States and internationally?
Stats of Viewpoints
Yes, their accountability will help ease the crisis
1 agrees
0 disagrees
No, this is not prosecutable
1 agrees
0 disagrees
Viewpoints
Add New Viewpoint

Yes, their accountability will help ease the crisis

Johnson and Johnson (J&J) are guilty of greatly exacerbating this problem, deceptively marketing drugs that are too strong and highly addictive. Furthermore J&J, and indeed any other pharmaceutical producer, medical organisation or government campaign, have not made enough effort in the last 20 years to provide clear information on downsides of opioids, meaning cases like this are becoming more common, with around 2000 opioid supply related lawsuits still pending in the United States. Other companies have already paid damages, and in the case of the above mentioned Oklahoma v Johnson lawsuit, J&J were ordered to pay $572 million in late August 2019. This case looks like a sign of what is to come for pharmaceutical manufacturers, and likewise a sign this case could make a significant dent in the Opioid addiction crisis in the US.

aljazeera.com/news/2019/05/opioid-crisis-oklahoma-takes-johnson-johnson-court-190528091839220.html theguardian.com/us-news/2019/may/28/johnson-johnson-opioid-trial-oklahoma businessinsider.com/oklahoma-judge-orders-jnj-pay-572-million-role-opioid-epidemic-2019-8

Agree
Disagree
Latest conversation
Daniel Halliday
Aug 30
Created

No, this is not prosecutable

This case will fall apart under the scrutiny of a judge, Johnson & Johnson have nothing to gain from generating these massive social problems and actively killing their customers, their model is to have their customers stay alive and needing medication, to be customers for longer and maximise profits. Johnson & Johnson have acted responsibly by just providing FDA-approved pain medication operating well within the law. The company earn only 46% of its revenue from all the pharmaceuticals they sell, making one particular medicine a small percentage of total profit, so to depict the company as purposefully profiteering from an opioid crisis is misleading. The only effect this will have in the US or internationally is to damage Johnson & Johnson’s reputation.

fool.com/investing/2017/08/23/how-johnson-johnson-makes-most-of-its-money.aspx

Agree
Disagree
Latest conversation
Daniel Halliday
Jun 3
Created
Translate